Literature DB >> 19857640

Sarcoidosis: epidemiology, etiology, pathogenesis, and genetics.

Angeline Lazarus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19857640     DOI： 10.1016/j.disamonth.2009.04.008

Source DB:  PubMed          Journal:  Dis Mon        ISSN： 0011-5029            Impact factor:   3.800


× No keyword cloud information.
  24 in total

1.  Prevalence of immune disease in patients with wounds presenting to a tertiary wound healing centre.

Authors:  Victoria K Shanmugam; Amber Schilling; Anthony Germinario; Mihriye Mete; Paul Kim; John Steinberg; Christopher E Attinger
Journal:  Int Wound J       Date:  2011-12-14       Impact factor: 3.315

Review 2.  Selected Giant Cell Rich Lesions of the Temporal Bone.

Authors:  Anthony P Martinez; Jorge Torres-Mora
Journal:  Head Neck Pathol       Date:  2018-08-01

Review 3.  The puzzling clinical spectrum and course of juvenile sarcoidosis.

Authors:  Andrew Fretzayas; Maria Moustaki; Olga Vougiouka
Journal:  World J Pediatr       Date:  2011-05-15       Impact factor: 2.764

4.  M2 polarized macrophages and giant cells contribute to myofibrosis in neuromuscular sarcoidosis.

Authors:  Stefan Prokop; Frank L Heppner; Hans H Goebel; Werner Stenzel
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

Review 5.  The potential of the immunological markers of sarcoidosis in exhaled breath and peripheral blood as future diagnostic and monitoring techniques.

Authors:  Hasib Ahmadzai; Denis Wakefield; Paul S Thomas
Journal:  Inflammopharmacology       Date:  2011-02-13       Impact factor: 4.473

6.  Sarcoidosis of The Breasts - When Should It Be Considered? a Case Report.

Authors:  Dominika Jaguś; Ivan Yafimtsau; Robert K Mlosek; Luiza Jonczak; Katarzyna Roszkowska-Purska; Katarzyna Dobruch-Sobczak
Journal:  J Ultrason       Date:  2022-04-27

7.  Sarcoidosis and chronic hepatitis C: a case report.

Authors:  Vadim Brjalin; Riina Salupere; Valentina Tefanova; Kaiu Prikk; Natalia Lapidus; Enn Jõeste
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742

8.  FCGR3A and FCGR3B copy number variations are risk factors for sarcoidosis.

Authors:  Jianming Wu; Yunfang Li; Weihua Guan; Kevin Viken; David M Perlman; Maneesh Bhargava
Journal:  Hum Genet       Date:  2016-04-08       Impact factor: 5.881

9.  Expression of hypoxia-inducible factor (HIF)-1a-vascular endothelial growth factor (VEGF)-inhibitory growth factor (ING)-4- axis in sarcoidosis patients.

Authors:  Argyris Tzouvelekis; Paschalis Ntolios; Andreas Karameris; Anastasios Koutsopoulos; Panagiotis Boglou; Andreas Koulelidis; Kostas Archontogeorgis; George Zacharis; Fotis Drakopanagiotakis; Paschalis Steiropoulos; Stavros Anevlavis; Vlassis Polychronopoulos; Dimitrios Mikroulis; Demosthenes Bouros
Journal:  BMC Res Notes       Date:  2012-11-26

10.  A Difficult Case of Hodgkin Lymphoma with Differential Diagnosis of Tuberculosis and Sarcoidosis.

Authors:  Nilüfer Göknar; Erkan Çakır; Fatma Betül Çakır; Ozgur Kasapcopur; Gulcin Yegen; Ahmet Hakan Gedik; Faruk Oktem
Journal:  Hematol Rep       Date:  2015-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.